Stanford University
Showing 30,761-30,770 of 35,007 Results
-
Nhi Ngoc Truong
Research Intern, Contingent
Staff, Program-Koyejo, O.BioNhi is an undergraduate researcher in the Stanford Trustworthy AI Research (STAIR) Lab, advised by Professor Sanmi Koyejo. She studies how we measure the reliability of AI systems, with a focus on the validity of AI benchmarks, meaning whether an evaluation really captures what it claims to and when its results can be trusted. Her current work looks at the assumptions built into widely used language model benchmarks and how to test them more carefully. Her earlier research on language models has appeared at leading natural language processing venues, including co-first-authored work at NAACL 2024 and an ICLR 2024 workshop. Outside of research, she plays in the symphonic band, badminton, and is taking up rock climbing.
-
Albert Tsai, M.D., Ph.D.
Assistant Professor of Pathology
BioDr. Tsai received his undergraduate training at the University of California, Los Angeles (B.S., Biochemistry, summa cum laude), followed by combined medical and graduate training at the University of Southern California (M.D., Ph.D., Biochemistry). He completed anatomic and clinical pathology (AP/CP) residency and hematopathology fellowship at Stanford University, receiving board certification in AP/CP and hematopathology. As an instructor, he performed clinical diagnostic duties on the hematopathology service while doing postdoctoral training in the laboratory of Dr. Sean Bendall, with funding from the Damon Runyon Cancer Research Foundation.
As a physician and hematopathologist, he seeks to mechanistically dissect myelodysplastic syndromes (MDS) using highly-multiplexed immunophenotyping — mass cytometry / cytometry by time-of-flight (CyTOF) and multiplexed ion beam imaging (MIBI). MDS is an especially complex and heterogeneous disease of abnormal blood cell development with increasing prevalence and few treatments. By combining practical experience clinically diagnosing MDS, next generation single cell proteomic approaches, fundamental discoveries in the biology of MDS, and knowledge of clinical laboratory testing, we hope to develop new clinical diagnostics for personalizing MDS therapies and therapeutic monitoring.
His clinical diagnostic duties are on the hematopathology service, primarily in the diagnosis of MDS, leukemias, lymphomas, and other hematopoietic diseases from blood, bone marrow, and tissue samples.
